These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 15516842

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D, Jansen V, Ostrer H.
    Arch Intern Med; 1998 Apr 13; 158(7):777-81. PubMed ID: 9554684
    [Abstract] [Full Text] [Related]

  • 3. Carrier screening panels for Ashkenazi Jews: is more better?
    Leib JR, Gollust SE, Hull SC, Wilfond BS.
    Genet Med; 2005 Mar 13; 7(3):185-90. PubMed ID: 15775754
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.
    Peleg L, Frisch A, Goldman B, Karpaty M, Narinsky R, Bronstein S, Frydman M.
    Eur J Hum Genet; 1998 Mar 13; 6(2):185-6. PubMed ID: 9781065
    [Abstract] [Full Text] [Related]

  • 7. Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.
    Brandt-Rauf SI, Raveis VH, Drummond NF, Conte JA, Rothman SM.
    Am J Public Health; 2006 Nov 13; 96(11):1979-88. PubMed ID: 17018815
    [Abstract] [Full Text] [Related]

  • 8. Selected genetic disorders affecting Ashkenazi Jewish families.
    Weinstein LB.
    Fam Community Health; 2007 Nov 13; 30(1):50-62. PubMed ID: 17149032
    [Abstract] [Full Text] [Related]

  • 9. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R, Pereira Lda V.
    Sao Paulo Med J; 2001 Jul 05; 119(4):146-9. PubMed ID: 11500789
    [Abstract] [Full Text] [Related]

  • 10. Cancer in Jews: introduction and overview.
    Lynch HT, Rubinstein WS, Locker GY.
    Fam Cancer; 2004 Jul 05; 3(3-4):177-92. PubMed ID: 15516840
    [Abstract] [Full Text] [Related]

  • 11. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM, Caskey CT, Richards CS.
    Hum Mutat; 1996 Jul 05; 8(2):116-25. PubMed ID: 8844209
    [Abstract] [Full Text] [Related]

  • 12. Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.
    Karpati M, Gazit E, Goldman B, Frisch A, Colombo R, Peleg L.
    Neurogenetics; 2004 Feb 05; 5(1):35-40. PubMed ID: 14648242
    [Abstract] [Full Text] [Related]

  • 13. Prenatal genetic screening in the Ashkenazi Jewish population.
    Zinberg RE, Kornreich R, Edelmann L, Desnick RJ.
    Clin Perinatol; 2001 Jun 05; 28(2):367-82. PubMed ID: 11499058
    [Abstract] [Full Text] [Related]

  • 14. Carrier screening for genetic disorders in individuals of Ashkenazi Jewish descent.
    Langlois S, Wilson RD, GENETICS COMMITTEE, CCMG PRENATAL DIAGNOSIS COMMITTEE.
    J Obstet Gynaecol Can; 2006 Apr 05; 28(4):324-332. PubMed ID: 16776912
    [No Abstract] [Full Text] [Related]

  • 15. The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility.
    Kedar-Barnes I, Rozen P.
    Fam Cancer; 2004 Apr 05; 3(3-4):193-9. PubMed ID: 15516841
    [Abstract] [Full Text] [Related]

  • 16. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.
    Risch N, de Leon D, Ozelius L, Kramer P, Almasy L, Singer B, Fahn S, Breakefield X, Bressman S.
    Nat Genet; 1995 Feb 05; 9(2):152-9. PubMed ID: 7719342
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L, Webb BD, Birch AH, Elkhoury L, McCarthy J, Cai X, Oishi K, Mehta L, Diaz GA, Edelmann L, Kornreich R.
    Clin Genet; 2017 Apr 05; 91(4):599-604. PubMed ID: 27415407
    [Abstract] [Full Text] [Related]

  • 18. ITD in Ashkenazi Jews--genetic drift or selection?
    Zoossmann-Diskin A.
    Nat Genet; 1995 Sep 05; 11(1):13-5. PubMed ID: 7550306
    [No Abstract] [Full Text] [Related]

  • 19. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J, Leventhal A.
    Isr Med Assoc J; 2000 Sep 05; 2(9):665-7. PubMed ID: 11062764
    [Abstract] [Full Text] [Related]

  • 20. Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
    Frisch A, Colombo R, Michaelovsky E, Karpati M, Goldman B, Peleg L.
    Hum Genet; 2004 Mar 05; 114(4):366-76. PubMed ID: 14727180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.